| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $284,887,792 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM147018 | Methylotrophs: underexplored bacteria for discovering novel natural products and biochemistry | 000 | 3 | NIH | 6/4/2024 | $385,000 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23NS105920 | Photophobia and Pupillary Autonomic Dysfunction as Biomarkers of Post-Traumatic Headache | 000 | 5 | NIH | 4/3/2024 | $196,151 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21CA280224 | MAIT cells as a therapeutic approach for gastrointestinal cancers | 000 | 1 | NIH | 5/8/2024 | $384,092 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U54CK000602 | Intermountain Program on Antibiotic Resistance and microbial Threats (IMPART) | 00 | 4 | CDC | 4/22/2024 | $599,996 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK125745 | Sex steroid signaling and adaptive growth of the intestine | 000 | 4 | NIH | 3/1/2024 | $425,434 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31CA287994 | Targeting reactive lipid aldehydes in lung cancer cachexia | 000 | 1 | NIH | 6/25/2024 | $44,543 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM143117 | Integrating Stochasticity into Biomolecular Mechanisms: A New Direction for Biomolecular Modeling | 000 | 4 | NIH | 8/21/2024 | $375,961 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01GM019559 | Intracellular Signaling by Bacterial Chemoreceptors | 001 | 51 | NIH | 5/14/2024 | $583,877 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK125745 | Sex steroid signaling and adaptive growth of the intestine | 001 | 4 | NIH | 6/10/2024 | $28,362 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM134936 | Evolutionary innovations from host-microbe interactions | 000 | 5 | NIH | 1/10/2024 | $343,125 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY026812 | Anatomical and functional organization of inter-areal feedback circuits in the visual cortex, and their impact on neuronal responses | 000 | 8 | NIH | 12/4/2023 | $264,880 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01GM144613 | PE in modulation of energy flux through OXPHOS | 002 | 4 | NIH | 7/12/2024 | $153,635 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI186663 | Architecture and dynamics of immature HIV lattice | 000 | 1 | NIH | 8/6/2024 | $571,685 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01GM144613 | PE in modulation of energy flux through OXPHOS | 001 | 4 | NIH | 7/11/2024 | $305,000 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U48DP006855 | Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics | 00 | 1 | CDC | 8/26/2024 | $299,998 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R56AR067196 | Biomechanics of Reverse Total Shoulder Arthroplasty | 000 | 6 | NIH | 9/9/2024 | $304,233 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01GM144613 | PE in modulation of energy flux through OXPHOS | 000 | 3 | NIH | 1/5/2024 | $103,268 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | NU01DD000050 | The Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) in Utah | 00 | 1 | CDC | 8/5/2024 | $450,000 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI181021 | Immunoregulatory roles for exosomes in the gastrointestinal tract | 001 | 1 | NIH | 9/3/2024 | $76,704 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31GM150221 | Mechanism of Substrate Unfolding by the AAA+ ATPase p97 and Binding Partners | 000 | 2 | NIH | 6/12/2024 | $48,974 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R25HL161608 | RUUTEs: Summer Undergraduate Research Experience (SURE) for Minorities | 000 | 2 | NIH | 2/20/2024 | $163,620 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK133270 | Share plus: Continuous Glucose Monitoring with Data Sharing in Older Adults with T1D and Their Care Partners | 000 | 2 | NIH | 2/26/2024 | $277,200 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK110358 | Regulation of WNK signaling by potassium and Mo25: structure, function and physiology | 000 | 10 | NIH | 7/16/2024 | $447,906 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI181021 | Immunoregulatory roles for exosomes in the gastrointestinal tract | 000 | 1 | NIH | 6/10/2024 | $690,339 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 South President's Circle, Room 210 | Salt Lake City | UT | 84112-9011 | SALT LAKE | USA | T9432908 | Advanced Nursing Education Workforce | 00 | 6 | HRSA | 5/29/2024 | $646,605 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK133270 | Share plus: Continuous Glucose Monitoring with Data Sharing in Older Adults with T1D and Their Care Partners | 001 | 2 | NIH | 5/6/2024 | $18,480 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33AT012329 | Specialized pro-resolving lipid mediators and treatment resistant depression | 000 | 1 | NIH | 3/18/2024 | $26,408 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM150766 | Integrated mass spectrometry-based chemoproteomic and genomic technologies for studying dynamic kinase interactomes | 000 | 2 | NIH | 4/3/2024 | $346,500 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21CA279773 | Regulation of glioblastoma cells by GABAergic neurons in human organoid-tumor chimeras | 000 | 2 | NIH | 3/13/2024 | $161,990 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL163849 | Developing novel therapies to improve blood stem cell transplantation outcomes | 000 | 3 | NIH | 8/15/2024 | $620,713 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM150766 | Integrated mass spectrometry-based chemoproteomic and genomic technologies for studying dynamic kinase interactomes | 001 | 2 | NIH | 7/29/2024 | $38,500 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31HL176119 | Advancing a biopsychosocial model of bedtime procrastination | 000 | 1 | NIH | 6/26/2024 | $40,562 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MD018517 | Addressing sleep health disparities from within: A community-engaged study to understanding sleep and cardiometabolic disease risk among women of color | 000 | 2 | NIH | 7/10/2024 | $724,679 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | DP2MH129958 | Uncovering the neural circuit and synaptic mechanisms underlying interval timing | 000 | 2 | NIH | 8/14/2024 | $924,000 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31HL176119 | Advancing a biopsychosocial model of bedtime procrastination | 001 | 1 | NIH | 6/26/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K08HD113835 | Individualization of Fetal Growth Assessment using Maternal Genetics and Explainable AI | 000 | 1 | NIH | 6/13/2024 | $171,720 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33AT012329 | Specialized pro-resolving lipid mediators and treatment resistant depression | 003 | 2 | NIH | 8/2/2024 | $42,767 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33AT012329 | Specialized pro-resolving lipid mediators and treatment resistant depression | 003 | 2 | NIH | 8/2/2024 | $4,814 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY035377 | Morphogenetic signaling from the cell surface to the nucleus during vertebrate eye development | 000 | 1 | NIH | 6/21/2024 | $714,141 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21CA279773 | Regulation of glioblastoma cells by GABAergic neurons in human organoid-tumor chimeras | 001 | 2 | NIH | 4/17/2024 | $8,998 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33AT012329 | Specialized pro-resolving lipid mediators and treatment resistant depression | 002 | 2 | NIH | 4/17/2024 | $134,438 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33AT012329 | Specialized pro-resolving lipid mediators and treatment resistant depression | 002 | 2 | NIH | 4/17/2024 | $346,702 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33AT012329 | Specialized pro-resolving lipid mediators and treatment resistant depression | 002 | 2 | NIH | 4/17/2024 | $54,161 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31HD115390 | Investigating the relationship between genome mutagenesis, fertility, and health in fertile and infertile men | 002 | 1 | NIH | 5/1/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31HD115390 | Investigating the relationship between genome mutagenesis, fertility, and health in fertile and infertile men | 001 | 1 | NIH | 5/1/2024 | $1,280 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23AR079778 | Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis | 000 | 3 | NIH | 5/31/2024 | $173,092 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA121118 | A High-Throughput Model for Human Melanoma | 001 | 14 | NIH | 4/16/2024 | $14,488 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T35EY026511 | Medical Student Research Program (MSRP) in Eye Health and Disease | 001 | 7 | NIH | 5/13/2024 | $37,096 |
| | 2024 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY034986 | Functional plasticity in retinal degenerative disease | 000 | 2 | NIH | 4/25/2024 | $385,000 |
|
